ES2147726T3 - NEW DERIVATIVES OF METHYLENBISPHOSPHONIC ACID. - Google Patents

NEW DERIVATIVES OF METHYLENBISPHOSPHONIC ACID.

Info

Publication number
ES2147726T3
ES2147726T3 ES92900821T ES92900821T ES2147726T3 ES 2147726 T3 ES2147726 T3 ES 2147726T3 ES 92900821 T ES92900821 T ES 92900821T ES 92900821 T ES92900821 T ES 92900821T ES 2147726 T3 ES2147726 T3 ES 2147726T3
Authority
ES
Spain
Prior art keywords
opt
alkyl
methylenbisphosphonic
acid
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900821T
Other languages
Spanish (es)
Inventor
Esko Pohjala
Marjaana Heikkila-Hoikka
Hannu Nikander
Hannu Hanhijarvi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Oy
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Application granted granted Critical
Publication of ES2147726T3 publication Critical patent/ES2147726T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings

Abstract

Bisphosphonic acid derivs. of formula (I) and their geometrical, optically active isomers and salts are new. In (I), R1, R2, R3 and R4 = opt. unsubstd. 1-10C alkyl or 3-10C cycloalkyl, aryl, aralkyl, silyl (SiR3) or H; where at least one of R1, R2, R3 and R4 is H and at least one is other than H; Q1 = H, OH, halo, NH2, or OR; where R' = 1-4C alkyl or acyl; Q2 = gp. of formula (i); Y = opt. substd. or opt. saturated or aromatic 6 membered heterocyclic gp. or carboxylic aromatic gp., where heterocycle contains 1-3 atoms from N, O and S; X = a bond, O, S or NR"; R" = H, 1-4C lower alkyl or acyl; n = 0 to 6; R' and R" = H, 1-4C lower alkyl. Specifically claimed are 17 cpds. including (((6-methyl -2-pyridinyl)amino) methylidene)bisphosphonic acid P,P'-diethyl ester.
ES92900821T 1990-12-20 1991-12-18 NEW DERIVATIVES OF METHYLENBISPHOSPHONIC ACID. Expired - Lifetime ES2147726T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI906295A FI89366C (en) 1990-12-20 1990-12-20 Process for the preparation of novel pharmacologically useful methylenebisphosphonic acid derivatives

Publications (1)

Publication Number Publication Date
ES2147726T3 true ES2147726T3 (en) 2000-10-01

Family

ID=8531620

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900821T Expired - Lifetime ES2147726T3 (en) 1990-12-20 1991-12-18 NEW DERIVATIVES OF METHYLENBISPHOSPHONIC ACID.

Country Status (25)

Country Link
US (1) US5393748A (en)
EP (1) EP0563107B1 (en)
JP (1) JP3224817B2 (en)
KR (1) KR100220157B1 (en)
CN (1) CN1030253C (en)
AT (1) ATE192452T1 (en)
AU (1) AU664541B2 (en)
CA (1) CA2098735C (en)
CZ (1) CZ288084B6 (en)
DE (1) DE69132164T2 (en)
DK (1) DK0563107T3 (en)
EE (1) EE02949B1 (en)
ES (1) ES2147726T3 (en)
FI (1) FI89366C (en)
HU (1) HUT64549A (en)
IE (1) IE914389A1 (en)
IL (1) IL100337A (en)
NO (1) NO302074B1 (en)
NZ (1) NZ241040A (en)
PL (1) PL169796B1 (en)
RU (1) RU2086556C1 (en)
SK (1) SK279601B6 (en)
TW (1) TW201752B (en)
WO (1) WO1992011269A1 (en)
ZA (1) ZA9110008B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI89365C (en) * 1990-12-20 1993-09-27 Leiras Oy PROCEDURE FOR THE FRAMEWORK OF THE PHARMACOLOGICAL PROCEDURE OF METHYLENBISPHOSPHONYRADERIVAT
US5157027A (en) * 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
EP0613373B1 (en) * 1991-11-22 2000-08-02 THE PROCTER & GAMBLE PHARMACEUTICALS, INC. Risedronate delayed-release compositions
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
GB9226879D0 (en) * 1992-12-23 1993-02-17 Iaf Biochem Int Anti-viral compounds
US6005107A (en) * 1992-12-23 1999-12-21 Biochem Pharma, Inc. Antiviral compounds
US6444656B1 (en) 1992-12-23 2002-09-03 Biochem Pharma, Inc. Antiviral phosphonate nucleotides
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
DE4435496A1 (en) * 1994-10-04 1996-04-11 Hoechst Ag Imidobisphosphoric acids, process for their preparation and use thereof
FI104901B (en) * 1997-10-20 2000-04-28 Leiras Oy New methylene bisphosphonic acid derivatives
WO2000014095A1 (en) 1998-09-09 2000-03-16 Metabasis Therapeutics, Inc. Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase
SE9903345D0 (en) 1999-09-17 1999-09-17 Astra Pharma Prod Novel process
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
PT1328277E (en) * 2000-10-27 2007-05-31 Schering Ag Bisphosphonic compounds for strengthening of cortical bone
US20030036537A1 (en) * 2001-07-16 2003-02-20 Marc Lecouvey Bisphosphonate derivatives, their preparations and uses
CA2451881A1 (en) * 2001-07-16 2003-01-30 Universite Paris 13 Novel bisphosphonate derivatives, their preparation methods and uses
FR2837490B1 (en) * 2002-03-21 2009-04-17 Univ Paris 13 NOVEL DERIVATIVES OF BISPHOSPHONATES, THEIR PREPARATIONS AND USES
WO2003070169A2 (en) * 2002-02-19 2003-08-28 Ilex Products, Inc. Aminodiphosphonate apolipoprotein e modulators
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
EP2310398A2 (en) * 2008-07-11 2011-04-20 Synthon B.V. Process for making 1-hydroxyalkylidene-1,1-biphosphonic acids
MX2012004769A (en) 2009-10-26 2012-08-08 Warner Chilcott Co Llc Bisphosphonate compounds for treating bone metabolism disorders.
TWI730039B (en) * 2016-01-29 2021-06-11 日商富士藥品股份有限公司 Novel bisphosphonic acid compound
CN108218918A (en) * 2018-03-01 2018-06-29 四川大学 Aryl is together with diphosphonic acid derivative preparation method and purposes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303139A (en) * 1962-01-27 1967-02-07 Henkel & Cie Gmbh Aminophosphonic acids and their derivatives as complex formers for metal ions
DE1617118C3 (en) * 1966-08-26 1975-04-03 Henkel & Cie Gmbh, 4000 Duesseldorf Methods for cleaning labeled rigid objects
US3962318A (en) * 1970-04-13 1976-06-08 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US3957858A (en) * 1970-04-13 1976-05-18 Monsanto Company Substituted ethane diphosphonic acids and salts and esters thereof
US4447256A (en) * 1977-07-20 1984-05-08 Nissan Chemical Industries, Ltd. N-(Unsubstituted or substituted pyridyl)aminomethylene-diphosphonic acids, herbicidal compositions containing same, their use for herbicides, and process for preparing same
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
GB8530603D0 (en) * 1985-12-12 1986-01-22 Leo Pharm Prod Ltd Chemical compounds
US4973576A (en) * 1987-03-10 1990-11-27 Yamanouchi Pharmaceutical Co., Ltd. Bisphophonic acid derivatives and pharmaceutical compositions containing the same
EP0356866A3 (en) * 1988-08-29 1991-03-27 E.R. SQUIBB & SONS, INC. Phosphorus-containing squalene synthetase inhibitors and method

Also Published As

Publication number Publication date
IE914389A1 (en) 1992-07-01
EP0563107B1 (en) 2000-05-03
CN1062534A (en) 1992-07-08
CZ121793A3 (en) 1994-10-19
PL169796B1 (en) 1996-08-30
IL100337A (en) 2000-12-06
FI906295A (en) 1992-06-21
CZ288084B6 (en) 2001-04-11
HUT64549A (en) 1994-01-28
JP3224817B2 (en) 2001-11-05
WO1992011269A1 (en) 1992-07-09
KR100220157B1 (en) 1999-10-01
JPH06504769A (en) 1994-06-02
US5393748A (en) 1995-02-28
NZ241040A (en) 1994-07-26
ZA9110008B (en) 1992-09-30
NO932255L (en) 1993-08-20
CN1030253C (en) 1995-11-15
EP0563107A1 (en) 1993-10-06
SK63493A3 (en) 1994-09-07
TW201752B (en) 1993-03-11
RU2086556C1 (en) 1997-08-10
EE02949B1 (en) 1996-12-16
CA2098735A1 (en) 1992-06-21
DE69132164D1 (en) 2000-06-08
SK279601B6 (en) 1999-01-11
AU664541B2 (en) 1995-11-23
AU9068291A (en) 1992-07-22
KR930703335A (en) 1993-11-29
HU9301781D0 (en) 1993-09-28
FI89366B (en) 1993-06-15
DK0563107T3 (en) 2000-09-25
CA2098735C (en) 2002-03-05
FI89366C (en) 1993-09-27
NO302074B1 (en) 1998-01-19
IL100337A0 (en) 1992-09-06
NO932255D0 (en) 1993-06-18
ATE192452T1 (en) 2000-05-15
FI906295A0 (en) 1990-12-20
DE69132164T2 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
ES2147726T3 (en) NEW DERIVATIVES OF METHYLENBISPHOSPHONIC ACID.
FI105686B (en) Process for the preparation of a therapeutically active compound and its physiologically useful salts
ES2147183T3 (en) NEW DERIVATIVES OF METHYLENEBISPHOSPHONIC ACID.
NO180540C (en) Analogous process for the preparation of therapeutically active cyclic amide derivative
KR910000765A (en) Phosphinic acid derivatives
ES2109988T3 (en) CEPHALOSPORINIC DERIVATIVES.
FI950259A0 (en) Novel acyclic diphosphonic acid derivatives containing amidine groups, process for their preparation and medicinal products containing these compounds
EG18031A (en) Dihydropyridiniellactols,process for their preparation and their use as medicaments
TH7294B (en) Carboxylkina Mido Cephalosporin

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563107

Country of ref document: ES